These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36617618)

  • 21. ASO Author Reflections: Usefulness of Visual Evaluation of PET in Predicting Prognosis after Lung Resection for Early-Stage Lung Adenocarcinoma and Selecting Candidates for Sublobar Resection.
    Kagimoto A; Tsutani Y; Okada M
    Ann Surg Oncol; 2021 Apr; 28(4):2076-2077. PubMed ID: 32965613
    [No Abstract]   [Full Text] [Related]  

  • 22. ASO Author Reflections: CTNNB1 and Fusion Genes as Predictors for Recurrence in Resected Early-Stage Lung Adenocarcinoma.
    Kim IA; Kim WS; Lee KY
    Ann Surg Oncol; 2021 Jul; 28(7):3994-3995. PubMed ID: 33151506
    [No Abstract]   [Full Text] [Related]  

  • 23. ASO Author Reflections: Long-Term Outcomes of Pulmonary Metastasectomy for Uterine Malignancies: A Multi-institutional Study in the Current Era.
    Kanzaki R
    Ann Surg Oncol; 2020 Oct; 27(10):3829-3830. PubMed ID: 32335750
    [No Abstract]   [Full Text] [Related]  

  • 24. ASO Author Reflections: The Clinical Use of Radiomics with Artificial Intelligence in Patients with Early-Stage Lung Cancer.
    Shimada Y
    Ann Surg Oncol; 2022 Dec; 29(13):8194-8195. PubMed ID: 36100830
    [No Abstract]   [Full Text] [Related]  

  • 25. ASO Author Reflections: Management of Malignant Peritoneal Mesothelioma.
    Cushman TR; Verma V; Simone CB
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):767-768. PubMed ID: 30421065
    [No Abstract]   [Full Text] [Related]  

  • 26. ASO Author Reflections: Which Is a Better Way to Describe Tumor Size of Lung Cancer: Tumor Volume or Diameter?
    Zhang X; Su XD
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):790-791. PubMed ID: 31620940
    [No Abstract]   [Full Text] [Related]  

  • 27. ASO Author Reflections: Impact of the Postoperative Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small Cell Lung Cancer Treated with Induction Chemoradiotherapy Followed by Surgery.
    Tsudaka S; Yamamoto H; Sato H; Toyooka S
    Ann Surg Oncol; 2021 Sep; 28(9):4891-4892. PubMed ID: 33634386
    [No Abstract]   [Full Text] [Related]  

  • 28. ASO Author Reflections: Survival Impact of N2 in Non-small Cell Lung Cancer.
    Clément-Duchêne C
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):944-945. PubMed ID: 30244416
    [No Abstract]   [Full Text] [Related]  

  • 29. ASO Author Reflections: Percutaneous Image-Guided Ablation and Multi-modality Management of Lung Metastases.
    Leppelmann KS; Fintelmann FJ
    Ann Surg Oncol; 2021 Oct; 28(11):5840-5841. PubMed ID: 33661461
    [No Abstract]   [Full Text] [Related]  

  • 30. ASO Author Reflections: Prognostic Nutritional Index-Based Risk Stratification for Lung Cancer.
    Okada S; Inoue M
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):954-955. PubMed ID: 30306371
    [No Abstract]   [Full Text] [Related]  

  • 31. Lung Cancer Surgery After Neoadjuvant Immunotherapy or Targeted Therapy: Knowledge, Judgment, and Skills Refined.
    Sepesi B
    Ann Thorac Surg; 2022 Oct; 114(4):1106-1107. PubMed ID: 34762869
    [No Abstract]   [Full Text] [Related]  

  • 32. ASO Author Reflections: An Evolving Skeletal Muscle Profiling-Towards Precise Host Phenotype and Prognostic Stratification in Non-small Cell Lung Cancer.
    Sun C; Anraku M; Nakajima J
    Ann Surg Oncol; 2022 Mar; 29(3):1825-1826. PubMed ID: 34802103
    [No Abstract]   [Full Text] [Related]  

  • 33. ASO Author Reflections: TNM 8th Edition: Stage I Non-small Cell Lung Cancer-Free from Recurrence and Adjuvant Therapy? How to Predict?
    Zeng Y; Mayne N; Yang CJ; Liang W; He J
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):745-746. PubMed ID: 31555939
    [No Abstract]   [Full Text] [Related]  

  • 34. ASO Author Reflections: Clinical Significance of Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Non-small Cell Lung Cancer.
    Iwasaki M; Ishihara S; Inoue M
    Ann Surg Oncol; 2022 Sep; 29(9):5708-5709. PubMed ID: 35614370
    [No Abstract]   [Full Text] [Related]  

  • 35. ASO Author Reflections: Old Song, New Sung-Extracapsular Extension in Lung Cancer in the Era of Eighth-Edition N Classification.
    Chen D; Ding Q; Wang W; Chen C; Chen Y
    Ann Surg Oncol; 2021 Apr; 28(4):2099-2100. PubMed ID: 32960391
    [No Abstract]   [Full Text] [Related]  

  • 36. ASO Author Reflections: Sublobar Resection En Route to Becoming the Standard of Care for cT1N0 Lung Adenocarcinoma.
    Lin MW; Chen JS
    Ann Surg Oncol; 2020 Mar; 27(3):716-717. PubMed ID: 31667722
    [No Abstract]   [Full Text] [Related]  

  • 37. ASO Author Reflections: Proposed Nodal Categories for Future Editions of the TNM Classification of Non-small Cell Lung Cancer.
    Li S; Wu N
    Ann Surg Oncol; 2021 Aug; 28(8):4517-4518. PubMed ID: 33423120
    [No Abstract]   [Full Text] [Related]  

  • 38. ASO Author Reflections: Patterns of Metastases in Patients with Obstructing Colorectal Cancer.
    Boeding JRE; Schreinemakers JMJ
    Ann Surg Oncol; 2020 Apr; 27(4):1056-1057. PubMed ID: 32048091
    [No Abstract]   [Full Text] [Related]  

  • 39. ASO Author Reflections: Could VAMLA be a Therapeutic Strategy in Selected Patients with Left-sided NSCLC?
    Yun JK; Kim YH
    Ann Surg Oncol; 2022 May; 29(5):2840-2841. PubMed ID: 34994894
    [No Abstract]   [Full Text] [Related]  

  • 40. ASO Author Reflections: Key Components of the Hedgehog Signaling Pathway as Prognostic Biomarkers in Non-small Cell Lung Cancer.
    Herreros-Pomares A; Jantus-Lewintre E
    Ann Surg Oncol; 2023 Feb; 30(2):1236-1237. PubMed ID: 36125572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.